文献速递类风湿关节炎

白细胞介素-6信号抑制对类风湿关节炎调节性T细胞亚群的影响及调节性T细胞与临床结局的关联

Effects of interleukin-6 signal inhibition on Treg subpopulations and association of Tregs with clinical outcomes in rheumatoid arthritis.
PubMed 文献 · Rheumatology (Oxford) · 2024-01-01

研究纳入40例开始托珠单抗(TCZ)治疗(联用或不联用甲氨蝶呤)的类风湿关节炎患者和11名健康对照,用流式细胞术分选调节性T细胞(Treg)亚群并随访至第52周。TCZ治疗后CD127low Treg、静息Treg(rTreg)、活化Treg(aTreg)及rTreg+aTreg比例均显著升高,第12周rTreg比例升高者关节炎 flare 显著更少。

要点

  • RA患者基线rTreg及rTreg+aTreg比例显著低于健康对照。
  • TCZ治疗后CD127low Treg、rTreg、aTreg及rTreg+aTreg比例均显著升高。
  • 第12周rTreg比例升高者观察期间关节炎flare显著更少。

核心结论

  • 阻断IL-6受体(TCZ)可升高功能性Treg亚群rTreg的比例。
  • rTreg早期升高者治疗过程更有利,rTreg升高可能反映IL-6信号抑制诱导的分子缓解。

研究设计与样本

  • 收集40例开始TCZ(联用或不联用MTX)的RA患者及11名健康对照的冻存外周血单个核细胞(PBMC)。
  • 基于表型和功能标志物用流式细胞术分选Treg,自基线至第52周序贯测定各Treg亚群比例。

主要发现

  • RA患者基线rTreg及rTreg+aTreg比例显著低于健康对照。
  • TCZ治疗后CD127low Treg、rTreg、aTreg及rTreg+aTreg比例均显著升高。
  • TCZ不联用MTX的患者rTreg升高。
  • 第12周rTreg比例升高的患者观察期间关节炎flare显著更少。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Anti-IL-6 receptor antibodies are clinically efficacious in the management of RA with an associated increase in Tregs; however, the role of functional Treg subsets has yet to be clarified. This study aimed to evaluate how functional Treg subsets are altered by IL-6 receptor blockade and to analyse the relationship between these Treg subsets and the clinical outcome of RA. METHODS: We collected frozen peripheral blood mononuclear cells (PBMCs) from 40 patients with RA who started tocilizumab (TCZ) with or without MTX and 11 healthy controls (HCs). We fractionated Tregs with flow cytometry based on markers of phenotype and function and measured the proportions of detailed Treg subsets sequentially from baseline to week 52. RESULTS: The proportions of resting Tregs (rTregs) and rTregs+activated Tregs (aTregs) were significantly lower in RA patients at baseline than in HCs. The proportions of all those CD127low Tregs, rTregs, aTregs and rTregs+aTregs were significantly increased with TCZ treatment. In patients treated with TCZ without MTX, rTreg were increased. Patients with an increase in the proportion of rTregs at week 12 had significantly less arthritis flares during the observation period. CONCLUSIONS: Blocking the IL-6 receptor with TCZ increased the proportion of rTregs, a functional Treg subpopulation. Patients with an early increase in rTregs showed a favourable treatment course and this increase in rTregs may reflect molecular remission induced by IL-6 signal inhibition.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Yoshida H, Magi M, Tamai H, et al. Effects of interleukin-6 signal inhibition on Treg subpopulations and association of Tregs with clinical outcomes in rheumatoid arthritis. Rheumatology (Oxford). 2024. PMID: 38530780. doi:10.1093/rheumatology/keae196

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。